Literature DB >> 1490029

In vivo effects of growth hormone on thymus function in aging mice.

R G Goya1, M C Gagnerault, M C De Moraes, W Savino, M Dardenne.   

Abstract

It is well demonstrated that the normal functioning of the thymus gland is under neuroendocrine control. Thus, steroid, thyroid, and pituitary hormones can affect distinct structural and/or functional thymic parameters. Particularly growth hormone (GH) was shown to be capable of restoring some thymus functions in old individuals. This prompted us to carry out a multiparametric analysis of the thymus in young, middle-aged, and old mice, subjected to GH treatment lasting 3 or 6 weeks. For that, we treated animals with daily injections of ovine GH (2 micrograms/g BW). Although the general microarchitecture of the thymus remained unchanged following in vivo GH treatment, there was a clearcut increase in thymulin production, independent of the age group analyzed. Regarding the lymphoid compartment, we could not find evidence of changes in total thymocyte numbers nor in the subsets phenotypically defined by the expression of CD3, CD4, and CD8 antigens. Nonetheless, in GH-treated middle-aged and old mice, the concanavalin A-dependent proliferative response of thymocytes, as well as IL-6 production were enhanced compared to age-matched controls. These findings support the notion that GH has a pleiotropic effect upon the thymus, functionally affecting both microenvironmental and lymphoid compartments of the organ.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1490029     DOI: 10.1016/0889-1591(92)90033-k

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  6 in total

1.  Role of oestrogen receptors alpha and beta in immune organ development and in oestrogen-mediated effects on thymus.

Authors:  M C Erlandsson; C Ohlsson; J A Gustafsson; H Carlsten
Journal:  Immunology       Date:  2001-05       Impact factor: 7.397

2.  Thymulin-based gene therapy and pituitary function in animal models of aging.

Authors:  Paula C Reggiani; Brenda Poch; Gloria M Cónsole; Omar J Rimoldi; Jose I Schwerdt; Victoria Tüngler; Margarita M Garcia-Bravo; Mireille Dardenne; Rodolfo G Goya
Journal:  Neuroimmunomodulation       Date:  2011-09-22       Impact factor: 2.492

3.  Thymulin, zinc and insulin-like growth factor-I (IGF-I) activity before and during recombinant growth hormone (rec-GH) therapy in children and adults with GH deficiency.

Authors:  E Mocchegiani; A Sartorio; L Santarelli; S Ferrero; N Fabris
Journal:  J Endocrinol Invest       Date:  1996-10       Impact factor: 4.256

Review 4.  The thymus-neuroendocrine axis: physiology, molecular biology, and therapeutic potential of the thymic peptide thymulin.

Authors:  Paula C Reggiani; Gustavo R Morel; Gloria M Cónsole; Claudio G Barbeito; Silvia S Rodriguez; Oscar A Brown; Maria Jose Bellini; Jean-Marie Pléau; Mireille Dardenne; Rodolfo G Goya
Journal:  Ann N Y Acad Sci       Date:  2009-02       Impact factor: 5.691

Review 5.  The role of interleukin-6 in certain age-related diseases.

Authors:  W B Ershler; W H Sun; N Binkley
Journal:  Drugs Aging       Date:  1994-11       Impact factor: 3.923

Review 6.  Infection, immunity and the neuroendocrine response.

Authors:  Paolo Borghetti; Roberta Saleri; Eugenio Mocchegiani; Attilio Corradi; Paolo Martelli
Journal:  Vet Immunol Immunopathol       Date:  2009-02-04       Impact factor: 2.046

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.